Janus Biosciences

Janus Biosciences is a biotech developing novel biomaterial skin substitutes for the treatment of acute and chronic wounds.

The platform is based on asymmetric Janus material architectures, in which opposing faces of the scaffold present distinct physicochemical properties to simultaneously support wound bed healing and provide external barrier protection.

The company's goal is to produce universally compatible, widely accessible skin substitutes applicable across a range of wound types and clinical settings.